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Background: S-nitrosylation of Ca2+ handling proteins contributes to cardiac excitation-contraction coupling. Cardiac injury impairs this coupling 
by diminishing the bioavailability and binding of nitric oxide required to improve the activity of Ca2+ handling proteins. Previous studies have 
shown that mice deficient in S-nitrosoglutathione reductase (GSNOR), an enzyme regulating S-nitrosothiol turnover, have improved cardiac function 
following myocardial infarction (MI). However, their ability to maintain Ca2+ handling homeostasis is unknown. The purpose of this study was to test 
the hypothesis that Ca2+ handling homeostasis is preserved in GSNOR knockout (GSNOR−−) mice following MI. 
Methods: 3-month old GSNOR−− and their corresponding wild-type (C57BL/6) mice were submitted to MI. Cardiac performance was assessed by 
serial echocardiography and hemodynamic analysis. Cardiac myocytes were isolated 8 weeks following MI and sarcomere relaxation, and calcium 
transient were analyzed. 
Results: Ejection fraction (EF%) for both GSNOR−− and C57BL/6 mice were equivalent at baseline and 1 week post-MI (58.3±1.2 vs 54.1±2.1 and 
21.3±3.0 vs 22.8±2.3, respectively), while at 8 weeks, EF% was improved in GSNOR−− mice (30.4±2.2 vs 21.4±2.8,p<0.05) and cardiac dimensions 
were preserved (EDV 102.1±7.0 vs 169.7±19.0 μL,p<0.001; and ESV 72.7±6.0 vs 139.6±19.7,p<0.001). Cardiac benefits were also shown by 
better hemodynamic parameters (EF%, 31.4±1.2 vs 22.2±3.1,p=0.048, and PDEV (mmHg), 84.72±3.20 vs 71.92±5.38,p=0.042). Both sarcomere 
relaxation and calcium decay (90%) were improved in GSNOR−− cardiac myocytes when these cells were stimulated with 0.5 and 1 Hz (0.07±0.01 
vs 0.12±0.02, and 0.25±0.01 vs 0.34±0.03; 0.07±0.01 vs 0.11±0.01, and 0.22±0.01 vs 0.27±0.01, respectively). In addition GSNOR−− cardiac 
myocytes required less time for Calcium decay (Tau) at both frequencies (0.08±0.01 to 0.11±0.01 vs 0.10±0.01 to 0.14±0.01 sec,p<0.05). 
Conclusions: Cardiac function depends on diastolic and systolic performance, and the higher ejection fraction in GSNOR−− mice was associated, 
at least in part, with an improvement in relaxation due to a decrease in the time of Ca2+ reuptake.
